Craft

Access Bio

Stock Price

₩6 K

2024-10-29

Market Capitalization

₩207.9 B

2024-10-29

Revenue

$82.5 M

FY, 2024

Access Bio Summary

Company Summary

Overview
Access Bio is a company dedicated to the prevention and early diagnosis of infectious diseases. It's engaged in research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The company uses in vitro diagnostic technology to provide immunochemical, biochemical, and molecular products.
Type
Public
Status
Active
Founded
2002
HQ
Somerset, NJ, US | view all locations
Website
https://accessbio.net
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

LocationsView all

4 locations detected

  • Somerset, NJ HQ

    United States

    65 Clyde Rd Suite A

  • Addis Ababa, Addis Ababa

    Ethiopia

    Megenagna Building, Equatorial Guinea St

  • Goryeong, Gyeongsangbuk-do

    Korea (Republic of)

    75 Ssangnim-myeon

  • Seoul, Seoul

    Korea (Republic of)

    16 Magokjungang 8-ro 1-gil, Gangseo-gu

Access Bio Financials

Summary Financials

Revenue (Q1, 2025)
$14.9M
Gross profit (Q1, 2025)
$6.4M
Net income (Q1, 2025)
($4.7M)
Cash (Q1, 2025)
$243.2M
EBIT (Q1, 2025)
($6.4M)
Enterprise value
$207.7B

Footer menu